Form 8-K - Current report:
SEC Accession No. 0001193125-22-162350
Filing Date
2022-05-27
Accepted
2022-05-27 16:12:58
Documents
12
Period of Report
2022-05-24
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d364091d8k.htm   iXBRL 8-K 22764
  Complete submission text file 0001193125-22-162350.txt   144549

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pstv-20220524.xsd EX-101.SCH 2885
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstv-20220524_lab.xml EX-101.LAB 17996
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstv-20220524_pre.xml EX-101.PRE 11281
6 EXTRACTED XBRL INSTANCE DOCUMENT d364091d8k_htm.xml XML 3389
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34375 | Film No.: 22977582
SIC: 3841 Surgical & Medical Instruments & Apparatus